Business · 23/08/2011Updated: 10/17/2026 · 1 min read
FDA Corrects Notice on Drug and Biologics Postmarketing Requirements
Summary
The Food and Drug Administration (FDA) is correcting a notice of availability that appeared in the Federal Register on August 4, 2011, due to an error in the document regarding postmarketing requirements and commitments for approved drug and biological products.
Original source language: Federal Register — Health and Human ServicesOpen original release →